The articles below appear in peer reviewed scientific journals. Not everyone will find this useful.

Expert Review of Haematology

  1.  Locatelli F, Algeri M, Merli P, Strocchio L. Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia. Expert Rev Hematol. 2018;11(2):129-43.

Leukaemia

  1. Sarah K Tasian, Jessica A Casas, David Posocco, Shilpa Gandre-Babbe, Alyssa L Gagne, Ge Liang, Mignon L Loh, Mitchell J Weiss, Deborah L French, and Stella T Chou, Mutation-Specific Signaling Profiles and Kinase Inhibitor Sensitivities of Juvenile Myelomonocytic Leukemia Revealed by Induced Pluripotent Stem Cells

Blood

  1. Worth A, Rao K, Webb D, Chessells J, Passmore J, Veys P. Successful treatment of juvenile myelomonocytic leukemia relapsing after stem cell transplantation using donor lymphocyte infusion. Blood. 2003;101(5):1713-4.
  2. Locatelli F, Nollke P, Zecca M, Korthof E, Lanino E, Peters C, et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood. 2005;105(1):410-9
  3. Furlan I, Batz C, Flotho C, Mohr B, Lubbert M, Suttorp M, et al. Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7. Blood. 2009;113(12):2867-8
  4. Locatelli F, Niemeyer CM. How I treat juvenile myelomonocytic leukemia. Blood. 2015;125(7):1083-90.

Nature Genetics

  1. Caye A, Strullu M, Guidez F, Cassinat B, Gazal S, Fenneteau O, et al. Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network. Nat Genet. 2015;47(11):1334-40.
  2. Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, et al. The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2015;47(11):1326-33
  3. Daniel B Lipka , Tania Witte , Reka Toth , Jing Yang , Manuel Wiesenfarth , Peter Nöllke , Alexandra Fischer , David Brocks , Zuguang Gu , Jeongbin Park , Brigitte Strahm , Marcin Wlodarski , Ayami Yoshimi, Rainer Claus , Michael Lübbert , Hauke Busch 12 13, Melanie Boerries 12 10 14, Mark Hartmann 4, Maximilian Schönung 4, Umut Kilik 4, Jens Langstein 4, Justyna A Wierzbinska 4 5, Caroline Pabst 15, Swati Garg 15, Albert Catalá 16, Barbara De Moerloose 17, Michael Dworzak 18, Henrik Hasle 19, Franco Locatelli 20, Riccardo Masetti 21, Markus Schmugge 22, Owen Smith 23, Jan Stary 24, Marek Ussowicz 25, Marry M van den Heuvel-Eibrink 26, Yassen Assenov 6, Matthias Schlesner 7 27, Charlotte Niemeyer 9 10, Christian Flotho 9 10, Christoph Plass RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia

Pending Publication

The first phase of the UK Research Study is complete and pending publication. In the interim, we have referenced the abstract and presentation.

  1. Louka E. et al, (2017) Blood (130) Molecular and functional characterisation of disease propagating stem cells in JMML. 

  2. Louka E. et al, (2017), Haematologica, 102, 265-265 Combination of deep phenotyping and targeted next generation sequencing as a diagnostic tool in children with suspected MDS. 

  3. Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia.

Last updated: 27th September 2020